Figures & data
Figure 1. Effect of Astragalosides IV (ASI) on high glucose-induced apoptosis in tubular epithelial cells. (A) ASI inhibited apoptosis in a concentration-dependent manner. (B) Time course of TUNEL fluorescence in different group. Data are expressed as the mean ± SEM of three independent experiments. *p < 0.05, compared with control group (CON). ▴p < 0.05, compared with high glucose group (HG).
![Figure 1. Effect of Astragalosides IV (ASI) on high glucose-induced apoptosis in tubular epithelial cells. (A) ASI inhibited apoptosis in a concentration-dependent manner. (B) Time course of TUNEL fluorescence in different group. Data are expressed as the mean ± SEM of three independent experiments. *p < 0.05, compared with control group (CON). ▴p < 0.05, compared with high glucose group (HG).](/cms/asset/9d112c75-254b-41c1-b9b8-4c3f249cfe34/irnf_a_867798_f0001_b.jpg)
Figure 2. Effect of ASI on expression of HGF and TGF-β1 in tubular epithelial cells. (A) ASI inhibited the secretion of TGF-β1 protein in concentration-dependent manner. (B) ASI promoted the secretion of HGF protein in concentration-dependent manner. (C) ASI inhibited the secretion of TGF-β1 protein in time-dependent manner. (D) ASI promoted the secretion of HGF protein in time-dependent manner. Data are expressed as the mean ± SEM of three independent experiments. ▴p < 0.05, ▴▴p < 0.01 compared with high glucose groups (HG).
![Figure 2. Effect of ASI on expression of HGF and TGF-β1 in tubular epithelial cells. (A) ASI inhibited the secretion of TGF-β1 protein in concentration-dependent manner. (B) ASI promoted the secretion of HGF protein in concentration-dependent manner. (C) ASI inhibited the secretion of TGF-β1 protein in time-dependent manner. (D) ASI promoted the secretion of HGF protein in time-dependent manner. Data are expressed as the mean ± SEM of three independent experiments. ▴p < 0.05, ▴▴p < 0.01 compared with high glucose groups (HG).](/cms/asset/68765e81-b881-40fc-94bd-0ef1f71784b1/irnf_a_867798_f0002_b.jpg)
Figure 3. Effect of ASI on tubular epithelial cells viability. Cells were treated with ASI (25, 50, 100 and 200 μg/mL) or vehicle for 24 h. Cell viability was determined with the Cell Counting Kit-8. Each treatment group is triplicate. Data are expressed as mean ± SEM.
![Figure 3. Effect of ASI on tubular epithelial cells viability. Cells were treated with ASI (25, 50, 100 and 200 μg/mL) or vehicle for 24 h. Cell viability was determined with the Cell Counting Kit-8. Each treatment group is triplicate. Data are expressed as mean ± SEM.](/cms/asset/c1b7880e-c80f-487d-af7a-8bb962aa7107/irnf_a_867798_f0003_b.jpg)
Figure 4. Effect of ASI on MAPK signaling pathway activation. (A) Bands of phospho-p38, phospho-ERK and phospho-JNK for the indicated concentration of ASI. (B) Semi-quantitative analysis of proteins showed that ASI inhibited the expression of phospho-p38 in concentration-dependent manner, but had no effect on the phospho-ERK and phospho-JNK. Each treatment group is triplicate. Data are expressed as the mean ± SEM. ▴p < 0.05, ▴▴p < 0.01 compared with high glucose groups (HG).
![Figure 4. Effect of ASI on MAPK signaling pathway activation. (A) Bands of phospho-p38, phospho-ERK and phospho-JNK for the indicated concentration of ASI. (B) Semi-quantitative analysis of proteins showed that ASI inhibited the expression of phospho-p38 in concentration-dependent manner, but had no effect on the phospho-ERK and phospho-JNK. Each treatment group is triplicate. Data are expressed as the mean ± SEM. ▴p < 0.05, ▴▴p < 0.01 compared with high glucose groups (HG).](/cms/asset/9b57266a-4345-4537-87b7-f3d9660bc317/irnf_a_867798_f0004_b.jpg)
Figure 5. The inhibitory effect of ASI and phospho-p38 inhibitor SB202190 on cell apoptosis in tubular epithelial cells under high glucose conditions. The cell apoptosis were then analyzed by caspase 3 activity (A) and TUNEL (B). Data are expressed as the mean ± SEM of three independent experiments. **p < 0.01 compared with control group (CON), ▴p < 0.05, ▴▴p < 0.01 compared with high glucose groups (HG).
![Figure 5. The inhibitory effect of ASI and phospho-p38 inhibitor SB202190 on cell apoptosis in tubular epithelial cells under high glucose conditions. The cell apoptosis were then analyzed by caspase 3 activity (A) and TUNEL (B). Data are expressed as the mean ± SEM of three independent experiments. **p < 0.01 compared with control group (CON), ▴p < 0.05, ▴▴p < 0.01 compared with high glucose groups (HG).](/cms/asset/224a0c48-1286-403d-8eff-9912a3da6454/irnf_a_867798_f0005_b.jpg)
Figure 6. Effect of HGF on the expression of phospho-p38. (A) Bands of phospho-p38 for the different concentration of HGF. (B) Semi-quantitative analysis of proteins showed that HGF inhibited the expression of phospho-p38 in concentration-dependent manner. Data are expressed as the mean ± SEM of three independent experiments. **p < 0.01, compared with control group (CON). ▴p < 0.05, ▴▴p < 0.01 compared with high glucose groups (HG).
![Figure 6. Effect of HGF on the expression of phospho-p38. (A) Bands of phospho-p38 for the different concentration of HGF. (B) Semi-quantitative analysis of proteins showed that HGF inhibited the expression of phospho-p38 in concentration-dependent manner. Data are expressed as the mean ± SEM of three independent experiments. **p < 0.01, compared with control group (CON). ▴p < 0.05, ▴▴p < 0.01 compared with high glucose groups (HG).](/cms/asset/d59dc09d-021b-40a0-843c-3441e5eec7dc/irnf_a_867798_f0006_b.jpg)
Figure 7. Therapeutic strategies for renal fibrosis. The duration of injury may determine whether the damaged tissues undergo recovery or fibrogenesis. The injury leads to a TGF-β1/HGF ratio that favors HGF, resulting in tissue repair and regeneration, whereas chronic injury dramatically changes the TGF-β1/ HGF ratio to favor TGF-β1, leading to tissue fibrosis. In the fibrotic kidney, the TGF-β1/HGF ratio is out of balance, and TGF-β1 signaling dominates. Thus, therapeutic strategies should include a reduction of TGF-β1 activity and/or supplementation of HGF. It is likely that ASI to influence the balance between TGF-β1 and HGF would be effective in ameliorating renal fibrosis.
![Figure 7. Therapeutic strategies for renal fibrosis. The duration of injury may determine whether the damaged tissues undergo recovery or fibrogenesis. The injury leads to a TGF-β1/HGF ratio that favors HGF, resulting in tissue repair and regeneration, whereas chronic injury dramatically changes the TGF-β1/ HGF ratio to favor TGF-β1, leading to tissue fibrosis. In the fibrotic kidney, the TGF-β1/HGF ratio is out of balance, and TGF-β1 signaling dominates. Thus, therapeutic strategies should include a reduction of TGF-β1 activity and/or supplementation of HGF. It is likely that ASI to influence the balance between TGF-β1 and HGF would be effective in ameliorating renal fibrosis.](/cms/asset/4b6929aa-f6e2-4eb2-b0f1-de4bdb7caedd/irnf_a_867798_f0007_b.jpg)